Neechi Okwor

Mr. Neechi Okwor

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2025 in Nature Water
Verified
Journal Article
Closed access
PDF file
ZZZhuoyue Zhang
Zhuoyue Zhang
KRKeith P. Reber
Keith P. Reber
NONeechi Okwor
Neechi Okwor
PGPriyansh D. Gujarati
Priyansh D. Gujarati
MVMatthew Vollmuth
Matthew Vollmuth
JUJohns University
Johns University

26 July 2026 in Viruses
Verified
Journal Article
Open access
PDF file
NEN. G. R. Dayan Elshan
N. G. R. Dayan Elshan
KWKaren C. Wolff
Karen C. Wolff
FWFrank O Weiss
Frank O Weiss
SGSourav Ghorai
Sourav Ghorai
GGGennadii Grabovyi
Gennadii Grabovyi
ACArnab K. Chatterjee
Arnab K. Chatterjee
The use of covalent warheads targeting the catalytic cysteine has been a cornerstone in the coronavirus main protease (Mpro) inhibitor development. Various electrophilic motifs have been explored, including aldehydes, nitriles, ketoamides, and hydroxymethyl ketones (HMKs). Recent efforts have mostly centered around nitrile warheads, given the success of Nirmatrelvir in the clinic. However, it is essential to identify and develop alternative chemotypes with distinct chemical and pharmacological profiles to prepare for future pandemics. Among such alternatives, HMKs are of particular interest because they balance reduced intrinsic electrophilicity with an excellent selectivity profile. Nevertheless, early HMK-based compounds, such as the clinical-stage Mpro inhibitor PF-00835231, suffered from poor oral bioavailability and therefore required intravenous administration, with or without prodrug derivatization of the hydroxyl group. In this work, we describe our efforts to advance the HMK field by discovering mCMX110, a lead compound that exhibits superior potency, increased unbound exposure in vivo, and favorable oral bioavailability in preclinical studies.

7 October 2026 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
KRKeith P. Reber
Keith P. Reber
JBJennafer Buckshaw
Jennafer Buckshaw
NONeechi Okwor
Neechi Okwor
GVGrace Vaillancourt
Grace Vaillancourt